Why Switch From Mounjaro To Wegovy Privately?
Can You Swap From Mounjaro To Wegovy Through Private Prescription?
The question of whether you can swap from Mounjaro to Wegovy is complex and requires individualised clinical assessment. Both medications are prescription-only medicines licensed for weight management, but they work through different mechanisms that may suit different patient profiles. Mounjaro (tirzepatide) targets both GIP and GLP-1 receptors, whilst Wegovy (semaglutide) specifically targets GLP-1 receptors alone. The private prescription route offers significant advantages over NHS pathways, eliminating the typical 6-month waiting lists and specialist referral requirements that can delay treatment transitions.
EverydayMeds provides expert clinical oversight for patients considering this switch, with our GPhC-registered pharmacy team (#9012878) reviewing each case individually. The private pathway allows for more flexible dosing protocols and personalised switching schedules that may not be available through standard NHS weight management services. Our prescribers can assess your current Mounjaro response, evaluate any side effects, and determine the most appropriate Wegovy starting dose to ensure treatment continuity.
Private Prescription Wegovy Pricing For Mounjaro Switchers
When you swap from Mounjaro to Wegovy privately, transparent pricing ensures no hidden costs or unexpected charges. EverydayMeds offers Wegovy starting at £79.99 for the 0.25mg initiation dose, with new customers applying discount code FIRST40 at checkout to reach this price. Our Intro Duo bundle at £169.99 provides both 0.25mg and 0.5mg doses, offering the first two months of treatment in a single order. Returning customers benefit from code DOSE25 for ongoing maintenance supplies.
For patients requiring a slower transition, our Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) costs £269.99 and allows extended time at the lowest dose. The maintenance 2.4mg dose is priced at £209.99 individually, or our Ultimate Stability Trio provides three months of maintenance supply for £649.99. Bundle options provide convenience and Reliable Supply continuity, particularly important when switching between different weight management medications.
Clinical Evidence Supporting Mounjaro To Wegovy Transitions
Research from the STEP clinical trials demonstrates Wegovy's efficacy across diverse patient populations, with participants achieving approximately 15% average weight loss at 68 weeks when combined with diet and exercise (Wilding et al., NEJM, 2021). The STEP programme included patients who had previously used other weight management approaches, suggesting successful transitions are clinically feasible. These trials provide the evidence base supporting Wegovy as an effective option for patients considering a switch from alternative treatments.
The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events with Wegovy treatment, which may influence clinical decisions when evaluating whether patients can swap from Mounjaro to Wegovy. Individual response patterns vary significantly, and some patients may find Wegovy's singular GLP-1 mechanism better tolerated than dual-receptor approaches, whilst others may prefer the multi-pathway effects of their current treatment.
How Wegovy Works Compared To Your Current Treatment
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural hormone GLP-1 that regulates appetite and glucose metabolism. Unlike Mounjaro's dual GIP/GLP-1 approach, Wegovy specifically targets the GLP-1 pathway to reduce appetite, increase feelings of fullness after smaller meals, and may help reduce food cravings by acting on brain appetite centres. This focused mechanism can be advantageous for patients who experienced specific side effects with dual-receptor treatments or those seeking a more targeted approach. The once-weekly injection schedule remains consistent between both medications, maintaining treatment convenience during the transition. Understanding these mechanistic differences helps inform the decision of whether you can swap from Mounjaro to Wegovy successfully.
Seamless Ordering Process For Treatment Transitions
EverydayMeds streamlines the process when you decide to swap from Mounjaro to Wegovy through our comprehensive online assessment system. The 3-minute clinical questionnaire captures your current treatment history, response patterns, and specific reasons for considering the switch. Our prescriber review typically takes 3 working days, though express 24-hour review is available for urgent transitions. Once approved, Wegovy ships via next-day delivery in temperature-controlled packaging to ensure medication integrity. The entire process eliminates the need for GP appointments, specialist referrals, or lengthy NHS waiting periods that can interrupt ongoing weight management progress.
Storage Advantages When Switching To Wegovy
Wegovy offers practical storage benefits that may influence your decision to swap from Mounjaro to Wegovy, particularly for frequent travellers or those with limited refrigeration access. The FlexTouch pen system can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Standard storage requires refrigeration at 2-8°C before first use, with the same dose escalation schedule as other weight management treatments. The pen design delivers precise doses through the established protocol: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance thereafter. This extended room temperature stability can simplify treatment adherence during the transition period.
Personalised Switching Protocols For Mounjaro Users
The decision of whether you can swap from Mounjaro to Wegovy depends heavily on individual factors including current dose, treatment duration, response patterns, and side effect profile. Some patients benefit from a direct transition maintaining equivalent therapeutic intensity, whilst others require modified starting doses to minimise transition-related side effects. EverydayMeds prescribers evaluate each case individually, considering factors such as previous dose escalation speed, gastrointestinal tolerance, and weight loss trajectory on current treatment.
Timing considerations are crucial when planning the switch, with many clinicians recommending completion of current pen supplies before initiating Wegovy to prevent medication waste. The private prescription pathway allows for flexible switching schedules that accommodate individual circumstances, work commitments, and social considerations that might affect treatment transitions. Our clinical team provides detailed guidance on managing the changeover period to optimise both safety and treatment continuity.
Start Your Wegovy Transition Today
Ready to explore whether you can swap from Mounjaro to Wegovy through private prescription? EverydayMeds makes this transition straightforward with expert clinical oversight and transparent pricing from £79.99. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 for ongoing supplies. Our comprehensive assessment evaluates your treatment history and provides personalised switching recommendations within 24 hours using express review. Visit our Wegovy collection to begin your clinical assessment and take the next step in your weight management journey. Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which treatment option best suits your individual needs and goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
